DSCM
ARKG icon

Del-Sette Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Del-Sette Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-99,135
Closed -$3.25M – 40
2023
Q4 		$3.25M Buy
+99,135
New +$2.7M 2.86% 12

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Del-Sette Capital Management's ARKG Position: Q1 2024 in Review

Del-Sette Capital Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2024, closing a stake of 99,135 shares — an estimated $3.25M sold.

Del-Sette Capital Management first reported a position in ARKG in Q4 2023 and held it in 1 quarter. The position peaked at $3.25M in Q4 2023. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.

  • Del-Sette Capital Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2024 after selling out during the quarter.
  • Del-Sette Capital Management sold 99,135 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $3.25M.
  • Del-Sette Capital Management first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 1 quarter.
  • Del-Sette Capital Management's ARK Genomic Revolution ETF position peaked at $3.25M in Q4 2023.
  • 284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.

Based on Del-Sette Capital Management's 13F filing for Q1 2024, filed 3 May 2024.